Jeffrey D. Janus

Biography

Mr. Janus was formally the Chief Executive Officer of ES Cell International Pte Ltd and led the ESI BIO Research Products Division at BioTime Inc. before joining Ascendance as its new president. Mr. Janus previously served as the CEO and founder of Lifeline Cell Technology, LLC, now a subsidiary of International Stem Cell, Inc., and was a member of the founding team that created Clonetics Corporation and the Clonetics brand of primary human cell systems, now owned by Lonza. In addition to his extensive experience in developing and selling cell-based products to the research market, Mr. Janus has led teams of scientists both internally and through external domestic and international collaborations with major academic institutions to conduct stem cell research. Mr. Janus has a Master’s Degree in Business Administration from California State University, San Diego and a Bachelor Degree in Biochemistry from the University of California at Davis. He is a published author of breakthrough papers in the development of parthenogenetic stem cells and cell-based assays and is an inventory on several patents in the stem cell field. 

Research Interest

Stem Cell Reserach